BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16849395)

  • 1. Expression pattern of the human FcRH/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia.
    Polson AG; Zheng B; Elkins K; Chang W; Du C; Dowd P; Yen L; Tan C; Hongo JA; Koeppen H; Ebens A
    Int Immunol; 2006 Sep; 18(9):1363-73. PubMed ID: 16849395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRTAs: a new family of immunoglobulinlike receptors differentially expressed in B cells.
    Miller I; Hatzivassiliou G; Cattoretti G; Mendelsohn C; Dalla-Favera R
    Blood; 2002 Apr; 99(8):2662-9. PubMed ID: 11929751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous expression of interleukin-18 and its receptor in B-cell lymphoproliferative disorders deriving from naive, germinal center, and memory B lymphocytes.
    Airoldi I; Raffaghello L; Cocco C; Guglielmino R; Roncella S; Fedeli F; Gambini C; Pistoia V
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):144-54. PubMed ID: 14734463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia.
    Colovai AI; Tsao L; Wang S; Lin H; Wang C; Seki T; Fisher JG; Menes M; Bhagat G; Alobeid B; Suciu-Foca N
    Cytometry B Clin Cytom; 2007 Sep; 72(5):354-62. PubMed ID: 17266150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT).
    Falini B; Tiacci E; Pucciarini A; Bigerna B; Kurth J; Hatzivassiliou G; Droetto S; Galletti BV; Gambacorta M; Orazi A; Pasqualucci L; Miller I; Kuppers R; Dalla-Favera R; Cattoretti G
    Blood; 2003 Nov; 102(10):3684-92. PubMed ID: 12881317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FcRH1: an activation coreceptor on human B cells.
    Leu CM; Davis RS; Gartland LA; Fine WD; Cooper MD
    Blood; 2005 Feb; 105(3):1121-6. PubMed ID: 15479727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a family of Fc receptor homologs with preferential B cell expression.
    Davis RS; Wang YH; Kubagawa H; Cooper MD
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9772-7. PubMed ID: 11493702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fc receptor-like 1-5 molecules are similarly expressed in progressive and indolent clinical subtypes of B-cell chronic lymphocytic leukemia.
    Kazemi T; Asgarian-Omran H; Hojjat-Farsangi M; Shabani M; Memarian A; Sharifian RA; Razavi SM; Jeddi-Tehrani M; Rabbani H; Shokri F
    Int J Cancer; 2008 Nov; 123(9):2113-9. PubMed ID: 18704934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin superfamily receptor translocation associated 2 protein on lymphoma cell lines and hairy cell leukemia cells detected by novel monoclonal antibodies.
    Ise T; Maeda H; Santora K; Xiang L; Kreitman RJ; Pastan I; Nagata S
    Clin Cancer Res; 2005 Jan; 11(1):87-96. PubMed ID: 15671532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy.
    Hatzivassiliou G; Miller I; Takizawa J; Palanisamy N; Rao PH; Iida S; Tagawa S; Taniwaki M; Russo J; Neri A; Cattoretti G; Clynes R; Mendelsohn C; Chaganti RS; Dalla-Favera R
    Immunity; 2001 Mar; 14(3):277-89. PubMed ID: 11290337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TOSO, the Fcmicro receptor, is highly expressed on chronic lymphocytic leukemia B cells, internalizes upon IgM binding, shuttles to the lysosome, and is downregulated in response to TLR activation.
    Vire B; David A; Wiestner A
    J Immunol; 2011 Oct; 187(8):4040-50. PubMed ID: 21908732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma.
    Ise T; Nagata S; Kreitman RJ; Wilson WH; Wayne AS; Stetler-Stevenson M; Bishop MR; Scheinberg DA; Rassenti L; Kipps TJ; Kyle RA; Jelinek DF; Pastan I
    Leukemia; 2007 Jan; 21(1):169-74. PubMed ID: 17051241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.
    Hüttmann A; Klein-Hitpass L; Thomale J; Deenen R; Carpinteiro A; Nückel H; Ebeling P; Führer A; Edelmann J; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2006 Oct; 20(10):1774-82. PubMed ID: 16932341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling.
    Gordiienko I; Shlapatska L; Kholodniuk V; Sklyarenko L; Gluzman DF; Clark EA; Sidorenko SP
    PLoS One; 2017; 12(10):e0185940. PubMed ID: 28982149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy.
    Daneshmanesh AH; Mikaelsson E; Jeddi-Tehrani M; Bayat AA; Ghods R; Ostadkarampour M; Akhondi M; Lagercrantz S; Larsson C; Osterborg A; Shokri F; Mellstedt H; Rabbani H
    Int J Cancer; 2008 Sep; 123(5):1190-5. PubMed ID: 18546292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYC expression and distribution in normal mature lymphoid cells.
    Cattoretti G
    J Pathol; 2013 Feb; 229(3):430-40. PubMed ID: 23165652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.
    Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL).
    Uhrmacher S; Schmidt C; Erdfelder F; Poll-Wolbeck SJ; Gehrke I; Hallek M; Kreuzer KA
    Leuk Res; 2011 Oct; 35(10):1360-6. PubMed ID: 21531460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal and aberrant expression of cytokines in neoplastic cells from chronic lymphocytic leukemias.
    Plate JM; Knospe WH; Harris JE; Gregory SA
    Hum Immunol; 1993 Apr; 36(4):249-58. PubMed ID: 8393431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of the inhibitory receptor BTLA in T-follicular helper cells and in B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.
    M'Hidi H; Thibult ML; Chetaille B; Rey F; Bouadallah R; Nicollas R; Olive D; Xerri L
    Am J Clin Pathol; 2009 Oct; 132(4):589-96. PubMed ID: 19762537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.